The Use of Intraperitoneal Ropivacaine in Bariatric Bypass Surgery
Status:
Completed
Trial end date:
2015-07-01
Target enrollment:
Participant gender:
Summary
This is a pilot study in a randomized, controlled, double-blinded format and will evaluate
the ability of a local anesthetic, Ropivacaine, to decrease pain after gastric bypass
surgery. The drug will be administered into the abdomen during a bariatric bypass surgery.
After surgery, patients who received Ropivacaine will be compared to those without
Ropivacaine to determine its effect on reducing pain, recovery of lung function, ability to
walk, and quality of life during recovery.